Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07266597

Micropulse Laser Photocoagulation in Diabetic Macular Edema

Micropulse Laser Photocoagulation Treatment of Diabetic Macular Edema ; 5 % Versus 15 % Duty Cycle

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the safety and efficacy of 532 nm subthreshold micropulse laser 5 % duty cycle compared with 15 % duty cycle in treatment of diabetic macular edema .

Detailed description

prospective interventional randomized comparative study that will be conducted on Patients with diabetic retinopathy who Are More than 18 years old with diabetic macular edema with a central retinal thickness \< 400 um and best corrected visual acuity between 6/18 and 6/60 . The participants will be divided randomly into two groups All Patients will receive single session of 532 nm subthreshold micropulse laser ,the following parameters will be used in all cases as follows,spot size : 200-µm ,exposure duration:200-ms ,power : 500-mW While duty cycle will differ between 2 groups as follows :- Group A : will be treated using 5 % duty cycle . Group B : will be treated using 15 % duty cycle . follow up visits as follows 1 week ,4 weeks 12 weeks after laser therapy .

Conditions

Interventions

TypeNameDescription
PROCEDUREmicropulse laser photocoagulationmicropulse laser photocoagulation in treatment of diabetic macular edema, 5% duty cycle
PROCEDUREmicropulse laser photocoagulationmicropulse laser photocoagulation in treatment of diabetic macular edema,15% duty cycle

Timeline

Start date
2025-11-30
Primary completion
2026-11-30
Completion
2027-02-01
First posted
2025-12-05
Last updated
2025-12-05

Source: ClinicalTrials.gov record NCT07266597. Inclusion in this directory is not an endorsement.